We supply rapid immunoassay kits, fluorescence-based readers (FIA), and portable PCR systems—building end‑to‑end screening programs from asymptomatic population checks to treatment pathways.
Early, accurate diagnosis shortens time‑to‑treatment, prevents spread, and optimizes care pathways. Below is how our portfolio maps to major disease classes.
Examples: SARS‑CoV‑2 Ag, HBsAg, HCV Ab, HIV‑1/2 Ab, Influenza A/B, RSV, TB Ag.
Examples: TnI, CK‑MB, Myoglobin, NT‑proBNP, D‑dimer, hs‑CRP.
Examples: TSH, Free T3/T4 (thyroid); LH/FSH (reproductive); hCG (pregnancy); Prolactin; Progesterone.
Examples: Total IgE and specific allergens such as pollen, dust‑mite, peanut, shellfish.
Reliable, equipment‑free screening. Clear C/T lines, fast time‑to‑result, ideal for clinics and outreach programs.
Targets: HCV Ab, HBsAg, HIV 1/2, Influenza, COVID‑19 Ag, TnI, CRP, and more.
Reader‑based, high sensitivity & specificity. Barcode & QC workflows, printable reports, LIS‑ready.
Use cases: cardiac markers, hormones, infectious diseases, inflammation.
Compact thermal cycling with real‑time detection. Accurate confirmation testing at the point of care.
Deployable in mobile labs and hospital wards.
From first‑line screening to advanced confirmation, our workflow integrates multiple validated diagnostic methods.
Screening using a lateral flow immunoassay based on colloidal gold nanoparticles or fluorescent nanoparticles allows fast detection in large groups.
If necessary, suspected cases can be confirmed using more advanced PCR methods, providing high sensitivity and specificity.
We collaborate with leading manufacturers and healthcare institutions across Asia, Europe, and the Middle East.
In Circle Co., LTD is a Korea‑based supplier of rapid diagnostics. We help ministries, hospitals, and NGOs design reliable, scalable testing programs with full regulatory documentation and on‑site training.
Tell us what you need. We’ll propose a kit list, reader options, and training plan within 1–2 business days.
Or email us at sales@incirclekorea.com
